HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief

This article was originally published in The Rose Sheet

Executive Summary

Avon names board member: Avon Products announces that V. Ann Hailey has been elected to become the 11th member of Avon's board of directors; she also has been appointed to serve on Avon's Audit Committee. Hailey currently serves on the board of W.W. Grainger, Inc., Federal Reserve Bank of Cleveland and Realogy Corporation. Previously she held management positions at Limited Brands, Inc. and was a member of its board of directors from 2001 to 2006. Andrea Jung, Avon CEO and chairwoman, welcomes Hailey, whose "extensive financial expertise and corporate strategy experience at prominent consumer product brand-name companies will enable her to make significant contributions to Avon as we continue to grow our business on a global scale.

You may also be interested in...



Turnaround Specialist Patriarch Partners Comes To Rescue Of Stila Cosmetics

Cosmetics brand Stila has been purchased for an undisclosed sum by private equity firm Patriarch Partners, which "concentrates on direct investments in distressed businesses," according to its Web site

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS015868

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel